Covid Treatment

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug

This trial has 5,197 participants who had not been exposed and showed a 77-percent reduced risk of developing symptomatic disease with no severe cases recorded.

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase

The study began in June 2021 and will continue till May 2022 and is being conducted in over 600 hospitals in 52 countries.

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths

The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or placebo.

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir

Molnupiravir is an oral antiviral agent, currently being studied in a Phase 3 trial for the treatment of non-hospitalised COVID-19 patients

COVID-19 patients with high blood sugar at higher risk of death even if they don’t have diabetes, study suggests

Researchers have found that the cumulative probability of mortality was significantly higher in patients with hyperglycemia - whether they had diabetes or not - as compared to those with normal blood sugar levels

WHO chief Tedros Adhanom Ghebreyesus lauds Narendra Modi’s ‘strong commitment’ to COVID vaccine development

The PM and world health body chief discussed the value of traditional medicinal systems, with the latter appreciating India’s Ayushman Bharat scheme and campaign against tuberculosis

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study

The drug is already approved and is used for the treatment of rheumatoid arthritis, an autoimmune disease that leads to joint inflammation and pain

With over 90,000 new infections, India’s coronavirus tally surpasses Brazil’s 41 lakh cases

India has been recording the world’s largest daily coronavirus caseload for a month even as the government pushes to revive a contracting economy

Coronavirus cases in India surge past 35 lakh; recovery rate rises to 76.61%, over 4.14 cr samples tested

It took 110 days for cases to reach one lakh, just 59 days more to go past the 10 lakh mark and by 23 August, India had reported 30 lakh infections

ICMR mulls setting up registry of hospitalised COVID-19 patients to collect data on response treatments

Fifteen institutions of national repute would be the registry sites and would mentor around 100 COVID-19 hospitals where the data would be collected